Doctor Miyo Nakano
Chiba University Graduate School of Medicine, Chiba (Japan)
Prognosis of hypertrophic cardiomyopathy in Japanese patients with an implantable cardioverter defibrillator -focus on apical hypertrophic cardiomyopathy
Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session: Arrhythmic risk stratification according to aetiology
Risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation -application of CHA2DS2-VASc and HAS-BLED scores-
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiogenic Embolism
Session: Stroke ePosters
Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator
Event: ESC Congress 2021 - The Digital Experience
Topic: Hypertrophic Cardiomyopathy
Session: Congress committee e-posters choice in arrhythmias and device therapy
Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure
Event: ESC Congress 2019
Topic: Oral Anticoagulation
Session: Epidemiology of atrial fibrillation
Impact of subclinical atrial fibrillation detected by cardiac implantable electronic devices on the risk of future embolic stroke events from Far East
Event: ESC Congress 2019
Topic: Cardiogenic Embolism
Session: Heart and brain interaction - Stroke
Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East
Event: ESC Congress 2018
Topic: Cardiogenic Embolism
Session: Adverse kidney infections and other complications after coronary interventions
Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate
Event: ESC Congress 2018
Topic: Risk Factors and Risk Assessment
Session: Ventricular arrhythmias and SCD. Epidemiology, prognosis, outcome
Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices
Event: ESC Congress 2017
Topic: Stroke
Session: Interventions, peripheral circulation, stroke, surgery - Miscellaneous
Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)
Session: Sudden cardiac death and implantable defibrillators
Risk classification for sudden cardiac death in japanese hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator in comparison between aha, jcs and esc guideline.
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Documents, Guidelines & Highlights
Session: Scientific documents and Guidelines
ESC 365 is supported by
